BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 38239049)

  • 1. Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease.
    Yue X; Zhou H; Wang S; Chen X; Xiao H
    Cancer Med; 2024 Feb; 13(3):e6799. PubMed ID: 38239049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation.
    Fujiwara H
    Front Immunol; 2021; 12():703298. PubMed ID: 34512627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) - Case series.
    Gray AN; Tobin NH; Moore TB; Li F; Aldrovandi GM
    Int J Med Microbiol; 2023 May; 313(3):151580. PubMed ID: 37121094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Promising Insight: The Potential Influence and Therapeutic Value of the Gut Microbiota in GI GVHD.
    Li J; Zhang X; Chen Y; Zheng Q; Zhao M; Jiang H
    Oxid Med Cell Longev; 2022; 2022():2124627. PubMed ID: 35571252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and acute graft-versus-host disease.
    Yoshioka K; Kakihana K; Doki N; Ohashi K
    Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease.
    van Lier YF; Vos J; Blom B; Hazenberg MD
    Gut Microbes; 2023; 15(1):2178805. PubMed ID: 36794370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft
    Le Bastard Q; Chevallier P; Montassier E
    World J Gastroenterol; 2021 Dec; 27(45):7792-7800. PubMed ID: 34963742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of microbiota in allogeneic hematopoietic stem cell transplantation.
    Chang CC; Hayase E; Jenq RR
    Expert Opin Biol Ther; 2021 Aug; 21(8):1121-1131. PubMed ID: 33412949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of the intestinal microbiota and microbial metabolites in acute GVHD.
    Lin D; Hu B; Li P; Zhao Y; Xu Y; Wu D
    Exp Hematol Oncol; 2021 Oct; 10(1):49. PubMed ID: 34706782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [GVHD: pathophysiology and novel agents].
    Ara T; Hashimoto D
    Rinsho Ketsueki; 2022; 63(9):1261-1269. PubMed ID: 36198552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The composition of the intestinal microbiota after allogeneic haematopoietic stem cell transplantation and its association with graft versus host disease as assessed by 16Sribosomal ribonucleic acid.
    Li DS; Wu YR; Du WH; Zhu YL; Zhang WJ; Fu Y; Yang GB
    J Physiol Pharmacol; 2023 Feb; 74(1):. PubMed ID: 37245237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
    Parco S; Benericetti G; Vascotto F; Palmisciano G
    Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of GVHD on the gut and intestinal microflora.
    Ji H; Feng S; Liu Y; Cao Y; Lou H; Li Z
    Transpl Immunol; 2024 Feb; 82():101977. PubMed ID: 38184214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gut microbiome, metabolites, and tissue metabolism in graft-versus-host disease].
    Fujiwara H
    Rinsho Ketsueki; 2022; 63(4):286-293. PubMed ID: 35491218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fecal microbiota transplantation for acute graft-versus-host disease of the gut].
    Kakihana K
    Rinsho Ketsueki; 2017; 58(5):499-505. PubMed ID: 28592766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
    Ingham AC; Kielsen K; Mordhorst H; Ifversen M; Aarestrup FM; Müller KG; Pamp SJ
    Microbiome; 2021 Jun; 9(1):148. PubMed ID: 34183060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease Is Not Associated With Significant Differences in Gut Taxonomic Composition Compared to Steroid-Sensitive Gastrointestinal Graft-Versus-Host Disease Immediately Before Onset of Disease.
    Zeng K; Brewster R; Kang JB; Tkachenko E; Brooks E; Bhatt AS; Fodor AA; Andermann TM
    Transplant Cell Ther; 2024 Feb; 30(2):237.e1-237.e9. PubMed ID: 37944820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of the intestinal microbiome to immune recovery after HCT.
    Wolfe AE; Markey KA
    Front Immunol; 2022; 13():988121. PubMed ID: 36059482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation.
    Gu Z; Xiong Q; Wang L; Wang L; Li F; Hou C; Dou L; Zhu B; Liu D
    Cancer; 2022 Apr; 128(7):1402-1410. PubMed ID: 35077579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.